[摘要] 目的 探讨精神分裂症慢性化的相关因素。 方法 收集2012年5月1日～2013年12月31日我院慢性精神分裂症患者及首发精神分裂症患者共400例，分为慢性组213例(慢性精神分裂症患者)与非慢性组187例(首发精神精神分裂症患者)。按照服用的药物分为四组，喹硫平组113例，利培酮组105例，奥氮平组131例，氯丙嗪组51例。比较两组患者的一般资料、治疗前后PANSS总分、四组不同治疗药物组治疗前后PANSS总分及疗效、复发与各项指标的相关性。 结果 治疗后2个月、6个月、12个月非慢性组PANSS总分与慢性组比较均明显较低(P, 百拇医药
 [关键词] 精神分裂症；慢性化

 [中图分类号] R749.3 [文献标识码] A [文章编号] 1673-9701(2015)08-0005-03

 [Abstract] Objective To investigate the relevant factors of chronic mental disorders classification. Methods All 400 cases of first-episode schizophrenia patients and hospital patients with chronic schizophrenia were selected from May 1， 2012 to December 31，2013，213 cases in chronic group (patients with chronic schizophrenia)， 187 cases in non-chronic group(non-chronic mental patients with schizophrenia). In accordance with medication all of them were divided into four groups， 113 cases in quetiapine group， 105 cases in risperidone group， 131 cases in olanzapine group， 51 cases in chlorpromazine group. General information， PANSS total score of two groups before and after treatment， PANSS total score of four different therapeutic groups before and after treatment， the relevance of efficacy， recurrence and the indicators were compared. Results PANSS total score of non-chronic group after treatment 2 months， 6 months， 12 months were significantly lower than chronic group(P, 百拇医药(冷小兵等) 第 1 2 3 页 下一页
 百拇医药网 http://www.100md.com/html/paper/1673-9701/2015/08/02.htm